What does Apotheek BAETS do?

Apotheek BAETS is a pharmacy in Duffel. Private Limited, started on 3 June 2004, 1 establishment.

What is the address of Apotheek BAETS?

The registered office of Apotheek BAETS is located at Kiliaanstraat 59, 2570 Duffel.

Is Apotheek BAETS still active?

Yes. According to the CBE (29 October 2026) Apotheek BAETS is active, legal situation “Normale toestand”, started on 3 June 2004.

Is Apotheek BAETS registered on Peppol?

Yes, Apotheek BAETS is registered on the Peppol network with ID 0208:0865585636.

What is the enterprise number of Apotheek BAETS?

The enterprise number of Apotheek BAETS is BE0865585636.

When was Apotheek BAETS founded?

Apotheek BAETS was founded on 3 June 2004.

Who are the directors of Apotheek BAETS?

According to the 2025 annual accounts, the directors of Apotheek BAETS are: Baets Invest BV.

Is Apotheek BAETS a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 3 June 2004; 4 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did Apotheek BAETS make in 2025?

Apotheek BAETS posted a profit after taxes of € 74,554 in financial year 2025.

What is the revenue of Apotheek BAETS?

As a small company, Apotheek BAETS is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 299,638.

How much does an employee at Apotheek BAETS earn?

The average wage cost per full-time employee at Apotheek BAETS was € 77,000 in 2025: staff costs of € 192,399 for 2.5 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does Apotheek BAETS have?

According to the 2025 annual accounts, Apotheek BAETS has 2.5 full-time equivalents (FTE).

Apotheek BAETS (Private Limited) - Duffel - BE0865585636

Dossier Apotheek BAETS, printed on 29 October 2026 from databakkes.be/en/0865585636/apotheek-baets. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

Apotheek BAETS from Duffel, company number BE0865585636, closed financial year 2025 with a result of € 74,554 after tax. For that financial year Apotheek BAETS recorded a gross margin of € 299,638 and equity of € 381,804. Compared with financial year 2024, the result moved from € 54,683 to € 74,554. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on March 27, 2026.

What it is worth Growing

€ 381,804

▲ 4% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 74,554

▲ 36% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 478,051

▲ 11% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 60,000 paid out

80 % of the profit went to the shareholders, mostly to BAETS INVEST (99 % of the shares). That is where the money ends up.

People and assets in 2025

Full-time equivalents

2.5

▼ 0.3 vs 2024

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 192,399

▲ 3% vs 2024

€ 77,000 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Debts at end 2025

Bank debt ≈ 10 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 138,929

▼ 9% vs 2024

€ 14,108 is repaid this year. At this pace the long-term loan is gone in ≈ 10 years.

Owed to suppliers

€ 109,084

▲ 7% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 17,889

▼ 38% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 252,255 Gross margin 2022: € 252,255 First fiscal year in the series	€ 240,690 Gross margin 2023: € 240,690 ▼ 5% vs 2022 (€ 252,255) Unfavourable step	€ 265,951 Gross margin 2024: € 265,951 ▲ 10% vs 2023 (€ 240,690) Favourable step	€ 299,638 Gross margin 2025: € 299,638 ▲ 13% vs 2024 (€ 265,951) Favourable step	▲ 13%
Profit after taxes	€ 64,257 Profit after taxes 2022: € 64,257 First fiscal year in the series	€ 30,316 Profit after taxes 2023: € 30,316 ▼ 53% vs 2022 (€ 64,257) Unfavourable step	€ 54,683 Profit after taxes 2024: € 54,683 ▲ 80% vs 2023 (€ 30,316) Favourable step	€ 74,554 Profit after taxes 2025: € 74,554 ▲ 36% vs 2024 (€ 54,683) Favourable step	▲ 36%
Equity	€ 333,751 Equity 2022: € 333,751 First fiscal year in the series	€ 357,567 Equity 2023: € 357,567 ▲ 7% vs 2022 (€ 333,751) Favourable step	€ 367,250 Equity 2024: € 367,250 ▲ 3% vs 2023 (€ 357,567) Favourable step	€ 381,804 Equity 2025: € 381,804 ▲ 4% vs 2024 (€ 367,250) Favourable step	▲ 4%
Total debts	€ 440,880 Total debts 2022: € 440,880 First fiscal year in the series	€ 494,470 Total debts 2023: € 494,470 ▲ 12% vs 2022 (€ 440,880) Unfavourable step	€ 530,538 Total debts 2024: € 530,538 ▲ 7% vs 2023 (€ 494,470) Unfavourable step	€ 496,476 Total debts 2025: € 496,476 ▼ 6% vs 2024 (€ 530,538) Favourable step	▼ 6%
Cash	€ 380,883 Cash 2022: € 380,883 First fiscal year in the series	€ 448,511 Cash 2023: € 448,511 ▲ 18% vs 2022 (€ 380,883) Favourable step	€ 429,997 Cash 2024: € 429,997 ▼ 4% vs 2023 (€ 448,511) Unfavourable step	€ 478,051 Cash 2025: € 478,051 ▲ 11% vs 2024 (€ 429,997) Favourable step	▲ 11%
Land & buildings	€ 134,200 Land & buildings 2022: € 134,200 First fiscal year in the series	€ 122,000 Land & buildings 2023: € 122,000 ▼ 9% vs 2022 (€ 134,200) Unchanged	€ 109,800 Land & buildings 2024: € 109,800 ▼ 10% vs 2023 (€ 122,000) Unchanged	€ 97,600 Land & buildings 2025: € 97,600 ▼ 11% vs 2024 (€ 109,800) Unchanged	▼ 11%
Retained profit	€ 315,151 Retained profit 2022: € 315,151 First fiscal year in the series	€ 338,967 Retained profit 2023: € 338,967 ▲ 8% vs 2022 (€ 315,151) Favourable step	€ 348,650 Retained profit 2024: € 348,650 ▲ 3% vs 2023 (€ 338,967) Favourable step	€ 363,204 Retained profit 2025: € 363,204 ▲ 4% vs 2024 (€ 348,650) Favourable step	▲ 4%
Dividend	€ 50,000 Dividend 2022: € 50,000 First fiscal year in the series	€ 6,500 Dividend 2023: € 6,500 ▼ 87% vs 2022 (€ 50,000) Unchanged	€ 45,000 Dividend 2024: € 45,000 ▲ € 38,500 vs 2023 (€ 6,500) Unchanged	€ 60,000 Dividend 2025: € 60,000 ▲ 33% vs 2024 (€ 45,000) Unchanged	▲ 33%
Bank debt	€ 179,027 Bank debt 2022: € 179,027 First fiscal year in the series	€ 166,022 Bank debt 2023: € 166,022 ▼ 7% vs 2022 (€ 179,027) Favourable step	€ 152,659 Bank debt 2024: € 152,659 ▼ 8% vs 2023 (€ 166,022) Favourable step	€ 138,929 Bank debt 2025: € 138,929 ▼ 9% vs 2024 (€ 152,659) Favourable step	▼ 9%
Balance sheet total	€ 774,631 Balance sheet total 2022: € 774,631 First fiscal year in the series	€ 852,037 Balance sheet total 2023: € 852,037 ▲ 10% vs 2022 (€ 774,631) Unchanged	€ 897,788 Balance sheet total 2024: € 897,788 ▲ 5% vs 2023 (€ 852,037) Unchanged	€ 878,280 Balance sheet total 2025: € 878,280 ▼ 2% vs 2024 (€ 897,788) Unchanged	▼ 2%
Employees (FTE)	-	0 Employees (FTE) 2023: 0 First fiscal year in the series	2.8 Employees (FTE) 2024: 2.8 Unchanged (0) Unchanged	2.5 Employees (FTE) 2025: 2.5 ▼ 0.3 vs 2024 (2.8) Unchanged	▼ 0.3

Key figures of Apotheek BAETS, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 30 April 2027.

What happened to Apotheek BAETS?

What happened at Apotheek BAETS in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Mar 27, 2026 New annual accounts for financial year 2025: profit of € 74,554 (▲ 36% vs 2024). Source: NBB ↗
2013 Baets Invest BV became a director. NBB
Jun 3, 2004 Start of the company according to the CBE. KBO
Jun 1, 2004 New establishment in Duffel. KBO

In short

From € 64,257 profit in 2022 to € 74,554 profit in 2025.

Paid € 24,284 in corporate taxes since 2022.

Best year ever: 2025, with € 74,554 profit.

On average € 119,900 of value added per employee in 2025.

Original PDFs at the National Bank ↗

Management

BAETS INVEST 99.5%

The stake of BAETS INVEST comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.

Apotheek BAETS

Behind Apotheek BAETS is Baets Invest BV. The shares are held by BAETS INVEST (99.5%).

Directors

According to the 2025 annual accounts

Baets Invest BV

Director · represented by Baets Sophie

since 2013

Shareholders

BAETS INVEST

99.5%

Participations

No participations in other companies reported.

Establishments

Establishment units

Physical locations of this company

Registered office

Kiliaanstraat 59

2570 Duffel

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 2 companies are registered at this address.

All companies at this address →

VL CONSULT

€ 112,030 gross margin · 2025

BAETS INVEST same network

€ 230,819 gross margin · 2025

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0865.585.636

VAT number

BE 0865.585.636

Registered office

Kiliaanstraat 59, 2570 Duffel

Names & denominations

Apotheek BAETS

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

3 June 2004

Peppol

Active · Active since 27 Nov 2025

Activities · NACE

Detailhandel in farmaceutische producten

Apothekers

View on CBE Public ↗ Annual accounts (NBB) ↗

Apotheek BAETS

Financials

What happened to Apotheek BAETS?

Management

Directors

Shareholders

Participations

Establishments

Establishment units

Who else lives here?

Details

Frequently asked questions